Alternatives to Precision BioSciences

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Clinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases.

Global provider of integrated temperature-controlled supply chain solutions for the life sciences industry.

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A biotechnology company developing genetic therapies for rare disorders.

Scalable, one-time curative in-vivo gene editing therapies.

Venture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Enzyme-based technology to break down alcohol in the stomach.

Biopharmaceutical company developing and commercializing CNS disease treatments.